Exicure Stock Today
| XCUR Stock | USD 7.70 0.50 6.10% |
PerformanceVery Weak
| Odds Of DistressVery High
|
Exicure is selling at 7.70 as of the 25th of February 2025; that is 6.1 percent decrease since the beginning of the trading day. The stock's lowest day price was 7.18. Exicure has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 28th of October 2024 and ending today, the 25th of February 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 22nd of May 2018 | Category Healthcare | Classification Health Care |
Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid technology. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois. Exicure operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 3.04 M outstanding shares of which 27.12 K shares are at this time shorted by private and institutional investors with about 0.2 trading days to cover. More on Exicure
Moving against Exicure Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Exicure Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| President CEO | Paul Kang | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsExicure can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Exicure's financial leverage. It provides some insight into what part of Exicure's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||
Exicure (XCUR) is traded on NASDAQ Exchange in USA. It is located in 2430 North Halsted Street, Chicago, IL, United States, 60614 and employs 6 people. Exicure is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 24.92 M. Exicure conducts business under Biotechnology sector and is part of Health Care industry. The entity has 3.04 M outstanding shares of which 27.12 K shares are at this time shorted by private and institutional investors with about 0.2 trading days to cover.
Exicure currently holds about 22.2 M in cash with (10.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.47.
Check Exicure Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Exicure is $24.92 Million. Exicure shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 72.15 percent of Exicure outstanding shares that are owned by insiders denotes they have been buying or selling the stock in recent months in anticipation of some upcoming event. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Exicure Ownership Details
Exicure Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Susquehanna International Group, Llp | 2024-09-30 | 0.0 | |
| Northern Trust Investments N A | 2024-12-31 | 0.0 | |
| Millennium Management Llc | 2024-09-30 | 0.0 | |
| Renaissance Technologies Corp | 2024-09-30 | 0.0 | |
| Vanguard Group Inc | 2024-09-30 | 0.0 | |
| Northwestern Mutual Wealth Management Co | 2024-09-30 | 0.0 | |
| Hrt Financial Llc | 2024-12-31 | 0.0 | |
| The Carlyle Group Inc | 2024-12-31 | 281.6 K | |
| Geode Capital Management, Llc | 2024-12-31 | 12.6 K | |
| Ubs Group Ag | 2024-12-31 | 1.6 K | |
| Tower Research Capital Llc | 2024-12-31 | 707 |
Exicure Historical Income Statement
Exicure Stock Against Markets
Exicure Corporate Executives
Elected by the shareholders, the Exicure's board of directors comprises two types of representatives: Exicure inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Exicure. The board's role is to monitor Exicure's management team and ensure that shareholders' interests are well served. Exicure's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Exicure's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Seung Baik | Secretary CFO | Profile |
Already Invested in Exicure?
The danger of trading Exicure is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Exicure is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Exicure. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Exicure is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additional Tools for Exicure Stock Analysis
When running Exicure's price analysis, check to measure Exicure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Exicure is operating at the current time. Most of Exicure's value examination focuses on studying past and present price action to predict the probability of Exicure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Exicure's price. Additionally, you may evaluate how the addition of Exicure to your portfolios can decrease your overall portfolio volatility.